Version: 2017-09-28
Format: classname (Label) [#subclasses][accuracy]

1. [NCIT:C2852](markdown/NCIT_C2852.md) (Adenocarcinoma) [573][66.24%]
1. [NCIT:C2862](markdown/NCIT_C2862.md) (Primary Myelofibrosis) [2][53.80%]
1. [NCIT:C2895](markdown/NCIT_C2895.md) (Benign Ovarian Neoplasm) [30][62.50%]
1. [NCIT:C2896](markdown/NCIT_C2896.md) (Benign Skin Neoplasm) [79][53.80%]
1. [NCIT:C2912](markdown/NCIT_C2912.md) (Burkitt Lymphoma) [33][54.55%]
1. [NCIT:C2916](markdown/NCIT_C2916.md) (Carcinoma) [1857][72.69%]
1. [NCIT:C2920](markdown/NCIT_C2920.md) (Malignant Skin Neoplasm) [211][59.91%]
1. [NCIT:C2921](markdown/NCIT_C2921.md) (Skin Basal Cell Carcinoma) [26][58.33%]
1. [NCIT:C2924](markdown/NCIT_C2924.md) (Ductal Breast Carcinoma In Situ) [3][80.00%]
1. [NCIT:C2926](markdown/NCIT_C2926.md) (Non-Small Cell Lung Carcinoma) [61][56.35%]
1. [NCIT:C2927](markdown/NCIT_C2927.md) (Papillary Carcinoma) [73][56.74%]
1. [NCIT:C2942](markdown/NCIT_C2942.md) (Bile Duct Adenoma) [4][65.82%]
1. [NCIT:C2946](markdown/NCIT_C2946.md) (Chondrosarcoma) [20][54.88%]
1. [NCIT:C2947](markdown/NCIT_C2947.md) (Chordoma) [4][55.00%]
1. [NCIT:C2948](markdown/NCIT_C2948.md) (Choriocarcinoma) [14][68.75%]
1. [NCIT:C2955](markdown/NCIT_C2955.md) (Colorectal Carcinoma) [123][54.88%]
1. [NCIT:C2972](markdown/NCIT_C2972.md) (Cystadenoma) [26][58.33%]
1. [NCIT:C2996](markdown/NCIT_C2996.md) (Dysgerminoma) [5][58.33%]
1. [NCIT:C3055](markdown/NCIT_C3055.md) (Giant Cell Tumor) [11][53.77%]
1. [NCIT:C3058](markdown/NCIT_C3058.md) (Glioblastoma) [35][55.75%]
1. [NCIT:C3059](markdown/NCIT_C3059.md) (Glioma) [216][59.81%]
1. [NCIT:C3062](markdown/NCIT_C3062.md) (Pancreatic Glucagon-Producing Neuroendocrine Tumor) [2][75.00%]
1. [NCIT:C3099](markdown/NCIT_C3099.md) (Hepatocellular Carcinoma) [35][55.48%]
1. [NCIT:C3107](markdown/NCIT_C3107.md) (Langerhans Cell Histiocytosis) [10][66.67%]
1. [NCIT:C3158](markdown/NCIT_C3158.md) (Leiomyosarcoma) [51][56.25%]
1. [NCIT:C3161](markdown/NCIT_C3161.md) (Leukemia) [208][66.46%]
1. [NCIT:C3164](markdown/NCIT_C3164.md) (Acute Basophilic Leukemia) [2][66.67%]
1. [NCIT:C3167](markdown/NCIT_C3167.md) (Acute Lymphoblastic Leukemia) [36][55.57%]
1. [NCIT:C3170](markdown/NCIT_C3170.md) (Acute Megakaryoblastic Leukemia) [2][60.00%]
1. [NCIT:C3172](markdown/NCIT_C3172.md) (Myeloid Leukemia) [100][62.82%]
1. [NCIT:C3174](markdown/NCIT_C3174.md) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive) [9][56.45%]
1. [NCIT:C3178](markdown/NCIT_C3178.md) (Chronic Myelomonocytic Leukemia) [4][53.80%]
1. [NCIT:C3181](markdown/NCIT_C3181.md) (Prolymphocytic Leukemia) [7][54.77%]
1. [NCIT:C3182](markdown/NCIT_C3182.md) (Acute Promyelocytic Leukemia with PML-RARA) [4][66.67%]
1. [NCIT:C3192](markdown/NCIT_C3192.md) (Lipoma) [41][54.98%]
1. [NCIT:C3193](markdown/NCIT_C3193.md) (Lipomatosis) [6][55.56%]
1. [NCIT:C3209](markdown/NCIT_C3209.md) (Follicular Lymphoma) [42][55.08%]
1. [NCIT:C3212](markdown/NCIT_C3212.md) (Lymphoplasmacytic Lymphoma) [10][55.56%]
1. [NCIT:C3230](markdown/NCIT_C3230.md) (Meningioma) [37][57.01%]
1. [NCIT:C3234](markdown/NCIT_C3234.md) (Mesothelioma) [48][55.28%]
1. [NCIT:C3242](markdown/NCIT_C3242.md) (Plasma Cell Myeloma) [4][62.50%]
1. [NCIT:C3246](markdown/NCIT_C3246.md) (Mycosis Fungoides) [6][62.50%]
1. [NCIT:C3249](markdown/NCIT_C3249.md) (Acute Myeloid Leukemia without Maturation) [2][80.80%]
1. [NCIT:C3250](markdown/NCIT_C3250.md) (Acute Myeloid Leukemia with Maturation) [2][68.30%]
1. [NCIT:C3264](markdown/NCIT_C3264.md) (Embryonal Neoplasm) [180][60.76%]
1. [NCIT:C3267](markdown/NCIT_C3267.md) (Wilms Tumor) [19][59.09%]
1. [NCIT:C3269](markdown/NCIT_C3269.md) (Schwannoma) [6][54.55%]
1. [NCIT:C3270](markdown/NCIT_C3270.md) (Neuroblastoma) [24][54.88%]
1. [NCIT:C3272](markdown/NCIT_C3272.md) (Neurofibroma) [11][56.25%]
1. [NCIT:C3288](markdown/NCIT_C3288.md) (Oligodendroglioma) [9][55.56%]
1. [NCIT:C3326](markdown/NCIT_C3326.md) (Adrenal Gland Pheochromocytoma) [10][58.33%]
1. [NCIT:C3329](markdown/NCIT_C3329.md) (Pituitary Gland Adenoma) [23][55.93%]
1. [NCIT:C3336](markdown/NCIT_C3336.md) (Polycythemia Vera) [2][53.85%]
1. [NCIT:C3358](markdown/NCIT_C3358.md) (Rhabdomyoma) [9][60.19%]
1. [NCIT:C3363](markdown/NCIT_C3363.md) (Sebaceous Gland Neoplasm) [10][66.67%]
1. [NCIT:C3377](markdown/NCIT_C3377.md) (Soft Tissue Neoplasm) [564][66.11%]
1. [NCIT:C3402](markdown/NCIT_C3402.md) (Tenosynovial Giant Cell Tumor) [2][52.69%]
1. [NCIT:C3411](markdown/NCIT_C3411.md) (Thymoma) [26][56.90%]
1. [NCIT:C3422](markdown/NCIT_C3422.md) (Trophoblastic Tumor) [25][76.92%]
1. [NCIT:C3434](markdown/NCIT_C3434.md) (Uterine Corpus Leiomyoma) [8][83.33%]
1. [NCIT:C3460](markdown/NCIT_C3460.md) (Grade 3 Follicular Lymphoma) [8][54.17%]
1. [NCIT:C3461](markdown/NCIT_C3461.md) (Immunoblastic Lymphoma) [9][57.14%]
1. [NCIT:C3465](markdown/NCIT_C3465.md) (Grade 1 Follicular Lymphoma) [6][54.17%]
1. [NCIT:C3466](markdown/NCIT_C3466.md) (T-Cell Non-Hodgkin Lymphoma) [113][58.32%]
1. [NCIT:C3473](markdown/NCIT_C3473.md) (Choroid Plexus Neoplasm) [7][66.67%]
1. [NCIT:C3491](markdown/NCIT_C3491.md) (Cecum Carcinoma) [2][75.00%]
1. [NCIT:C3493](markdown/NCIT_C3493.md) (Squamous Cell Lung Carcinoma) [13][54.77%]
1. [NCIT:C3502](markdown/NCIT_C3502.md) (Thyroid Gland Follicular Adenoma) [2][55.00%]
1. [NCIT:C3512](markdown/NCIT_C3512.md) (Lung Adenocarcinoma) [19][54.77%]
1. [NCIT:C3513](markdown/NCIT_C3513.md) (Esophageal Carcinoma) [47][55.18%]
1. [NCIT:C3520](markdown/NCIT_C3520.md) (Myeloid Sarcoma) [6][55.00%]
1. [NCIT:C3605](markdown/NCIT_C3605.md) (Benign Cardiac Neoplasm) [20][53.85%]
1. [NCIT:C3616](markdown/NCIT_C3616.md) (Benign Renal Pelvis Neoplasm) [2][58.33%]
1. [NCIT:C3624](markdown/NCIT_C3624.md) (Benign Retinal Neoplasm) [4][66.67%]
1. [NCIT:C3627](markdown/NCIT_C3627.md) (Benign Spinal Cord Neoplasm) [3][75.00%]
1. [NCIT:C3628](markdown/NCIT_C3628.md) (Benign Thyroid Gland Neoplasm) [3][54.17%]
1. [NCIT:C3629](markdown/NCIT_C3629.md) (Benign Adrenal Gland Neoplasm) [9][72.22%]
1. [NCIT:C3630](markdown/NCIT_C3630.md) (Benign Parathyroid Gland Neoplasm) [7][53.52%]
1. [NCIT:C3640](markdown/NCIT_C3640.md) (Stage 0 Skin Cancer) [3][66.67%]
1. [NCIT:C3641](markdown/NCIT_C3641.md) (Stage 0 Breast Cancer AJCC v6 and v7) [7][71.43%]
1. [NCIT:C3687](markdown/NCIT_C3687.md) (Renal Papillary Adenoma) [2][58.33%]
1. [NCIT:C3696](markdown/NCIT_C3696.md) (Subependymal Giant Cell Astrocytoma) [3][62.50%]
1. [NCIT:C3708](markdown/NCIT_C3708.md) (Germ Cell Tumor) [164][56.74%]
1. [NCIT:C3709](markdown/NCIT_C3709.md) (Epithelial Neoplasm) [2675][76.40%]
1. [NCIT:C3714](markdown/NCIT_C3714.md) (Epithelioid Sarcoma) [7][60.00%]
1. [NCIT:C3716](markdown/NCIT_C3716.md) (Primitive Neuroectodermal Tumor) [58][55.75%]
1. [NCIT:C3720](markdown/NCIT_C3720.md) (Anaplastic Large Cell Lymphoma) [28][55.28%]
1. [NCIT:C3721](markdown/NCIT_C3721.md) (Lymphomatoid Papulosis) [5][60.00%]
1. [NCIT:C3723](markdown/NCIT_C3723.md) (Lymphatic Vessel Neoplasm) [18][66.67%]
1. [NCIT:C3726](markdown/NCIT_C3726.md) (Adenomyoma) [2][53.51%]
1. [NCIT:C3727](markdown/NCIT_C3727.md) (Adenosquamous Carcinoma) [31][53.85%]
1. [NCIT:C3729](markdown/NCIT_C3729.md) (Malignant Mixed Neoplasm) [80][56.43%]
1. [NCIT:C3730](markdown/NCIT_C3730.md) (Mixed Mesodermal (Mullerian) Tumor) [51][54.31%]
1. [NCIT:C3737](markdown/NCIT_C3737.md) (Mesenchymal Chondrosarcoma) [4][75.00%]
1. [NCIT:C3743](markdown/NCIT_C3743.md) (Fibroepithelial Neoplasm) [22][55.00%]
1. [NCIT:C3746](markdown/NCIT_C3746.md) (Small Cell Sarcoma) [9][55.56%]
1. [NCIT:C3750](markdown/NCIT_C3750.md) (Alveolar Soft Part Sarcoma) [7][56.25%]
1. [NCIT:C3751](markdown/NCIT_C3751.md) (Smooth Muscle Neoplasm) [108][56.58%]
1. [NCIT:C3753](markdown/NCIT_C3753.md) (Germinoma) [2][83.33%]
1. [NCIT:C3758](markdown/NCIT_C3758.md) (Hepatocellular Adenoma) [3][58.33%]
1. [NCIT:C3762](markdown/NCIT_C3762.md) (Adenomatoid Tumor) [8][93.30%]
1. [NCIT:C3764](markdown/NCIT_C3764.md) (Adenomatous Polyp) [10][55.56%]
1. [NCIT:C3771](markdown/NCIT_C3771.md) (Lobular Breast Carcinoma) [9][55.56%]
1. [NCIT:C3772](markdown/NCIT_C3772.md) (Mucoepidermoid Carcinoma) [27][56.25%]
1. [NCIT:C3782](markdown/NCIT_C3782.md) (Cervical Intraepithelial Neoplasia) [13][54.26%]
1. [NCIT:C3786](markdown/NCIT_C3786.md) (Mesothelial Neoplasm) [49][58.33%]
1. [NCIT:C3787](markdown/NCIT_C3787.md) (Neuroepithelial Neoplasm) [307][62.29%]
1. [NCIT:C3788](markdown/NCIT_C3788.md) (Ganglioglioma) [2][57.14%]
1. [NCIT:C3789](markdown/NCIT_C3789.md) (Olfactory Neuroblastoma) [3][62.50%]
1. [NCIT:C3790](markdown/NCIT_C3790.md) (Ganglioneuroblastoma) [10][58.33%]
1. [NCIT:C3792](markdown/NCIT_C3792.md) (Squamous Cell Neoplasm) [279][59.81%]
1. [NCIT:C3794](markdown/NCIT_C3794.md) (Sex Cord-Stromal Tumor) [10][53.85%]
1. [NCIT:C3796](markdown/NCIT_C3796.md) (Gliosarcoma) [6][66.67%]
1. [NCIT:C3798](markdown/NCIT_C3798.md) (Malignant Peripheral Nerve Sheath Tumor) [18][55.56%]
1. [NCIT:C3800](markdown/NCIT_C3800.md) (Epithelioid Hemangioendothelioma) [8][55.56%]
1. [NCIT:C3801](markdown/NCIT_C3801.md) (Hemangioblastoma) [4][58.33%]
1. [NCIT:C3803](markdown/NCIT_C3803.md) (Blue Nevus) [2][66.67%]
1. [NCIT:C3808](markdown/NCIT_C3808.md) (Rhabdoid Tumor) [6][57.14%]
1. [NCIT:C3809](markdown/NCIT_C3809.md) (Neuroendocrine Neoplasm) [309][61.18%]
1. [NCIT:C3842](markdown/NCIT_C3842.md) (Urothelial Papilloma) [9][64.29%]
1. [NCIT:C3844](markdown/NCIT_C3844.md) (Gallbladder Carcinoma) [39][54.07%]
1. [NCIT:C3860](markdown/NCIT_C3860.md) (Extrahepatic Bile Duct Carcinoma) [30][58.33%]
1. [NCIT:C3861](markdown/NCIT_C3861.md) (Ependymal Tumor of Brain) [9][57.14%]
1. [NCIT:C3867](markdown/NCIT_C3867.md) (Fallopian Tube Carcinoma) [16][53.94%]
1. [NCIT:C3868](markdown/NCIT_C3868.md) (Gastrointestinal Stromal Tumor) [28][54.31%]
1. [NCIT:C3871](markdown/NCIT_C3871.md) (Nasopharyngeal Carcinoma) [34][53.85%]
1. [NCIT:C3873](markdown/NCIT_C3873.md) (Ovarian Germ Cell Tumor) [40][58.33%]
1. [NCIT:C3879](markdown/NCIT_C3879.md) (Thyroid Gland Medullary Carcinoma) [7][57.14%]
1. [NCIT:C3898](markdown/NCIT_C3898.md) (Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue) [22][54.66%]
1. [NCIT:C3915](markdown/NCIT_C3915.md) (Small Cell Carcinoma) [32][54.66%]
1. [NCIT:C3916](markdown/NCIT_C3916.md) (Parathyroid Gland Adenoma) [6][55.36%]
1. [NCIT:C3917](markdown/NCIT_C3917.md) (Vaginal Carcinoma) [18][62.50%]
1. [NCIT:C4004](markdown/NCIT_C4004.md) (Gastric Adenocarcinoma) [16][54.55%]
1. [NCIT:C4016](markdown/NCIT_C4016.md) (Malignant Bone Neoplasm) [85][57.68%]
1. [NCIT:C4017](markdown/NCIT_C4017.md) (Ductal Breast Carcinoma) [21][57.74%]
1. [NCIT:C4024](markdown/NCIT_C4024.md) (Esophageal Squamous Cell Carcinoma) [14][57.69%]
1. [NCIT:C4025](markdown/NCIT_C4025.md) (Esophageal Adenocarcinoma) [9][54.41%]
1. [NCIT:C4028](markdown/NCIT_C4028.md) (Cervical Squamous Cell Carcinoma, Not Otherwise Specified) [10][60.00%]
1. [NCIT:C4030](markdown/NCIT_C4030.md) (Urothelial Carcinoma) [52][56.27%]
1. [NCIT:C4032](markdown/NCIT_C4032.md) (Bladder Adenocarcinoma) [6][65.97%]
1. [NCIT:C4035](markdown/NCIT_C4035.md) (Thyroid Gland Papillary Carcinoma) [10][54.07%]
1. [NCIT:C4036](markdown/NCIT_C4036.md) (Myelodysplastic Syndrome with Ring Sideroblasts) [2][70.00%]
1. [NCIT:C4044](markdown/NCIT_C4044.md) (Laryngeal Squamous Cell Carcinoma) [9][55.91%]
1. [NCIT:C4047](markdown/NCIT_C4047.md) (Pilocytic Astrocytoma) [5][57.14%]
1. [NCIT:C4050](markdown/NCIT_C4050.md) (Oligoastrocytoma) [3][66.67%]
1. [NCIT:C4052](markdown/NCIT_C4052.md) (Vulvar Squamous Cell Carcinoma) [6][75.00%]
1. [NCIT:C4063](markdown/NCIT_C4063.md) (Myomatous Neoplasm) [159][62.69%]
1. [NCIT:C4074](markdown/NCIT_C4074.md) (Centroblastic Lymphoma) [7][56.25%]
1. [NCIT:C4092](markdown/NCIT_C4092.md) (Benign Epithelial Neoplasm) [181][59.48%]
1. [NCIT:C4115](markdown/NCIT_C4115.md) (Transitional Cell Papilloma) [11][61.11%]
1. [NCIT:C4120](markdown/NCIT_C4120.md) (Sarcomatoid Transitional Cell Carcinoma) [4][66.67%]
1. [NCIT:C4122](markdown/NCIT_C4122.md) (Papillary Transitional Cell Carcinoma) [8][54.17%]
1. [NCIT:C4129](markdown/NCIT_C4129.md) (Bile Duct Mucinous Cystic Neoplasm) [7][64.89%]
1. [NCIT:C4133](markdown/NCIT_C4133.md) (Tubular Adenoma) [9][51.76%]
1. [NCIT:C4143](markdown/NCIT_C4143.md) (Tubulovillous Adenoma) [8][51.76%]
1. [NCIT:C4146](markdown/NCIT_C4146.md) (Chromophobe Renal Cell Carcinoma) [2][54.17%]
1. [NCIT:C4159](markdown/NCIT_C4159.md) (Lipoadenoma) [2][75.00%]
1. [NCIT:C4194](markdown/NCIT_C4194.md) (Invasive Ductal Carcinoma, Not Otherwise Specified) [2][60.38%]
1. [NCIT:C4197](markdown/NCIT_C4197.md) (Acinar Cell Neoplasm) [10][54.98%]
1. [NCIT:C4199](markdown/NCIT_C4199.md) (Epithelial-Myoepithelial Carcinoma) [2][66.67%]
1. [NCIT:C4216](markdown/NCIT_C4216.md) (Sympathetic Paraganglioma) [15][59.09%]
1. [NCIT:C4217](markdown/NCIT_C4217.md) (Parasympathetic Paraganglioma) [7][56.25%]
1. [NCIT:C4237](markdown/NCIT_C4237.md) (Spindle Cell Melanoma) [2][90.82%]
1. [NCIT:C4247](markdown/NCIT_C4247.md) (Undifferentiated Pleomorphic Sarcoma) [8][53.94%]
1. [NCIT:C4248](markdown/NCIT_C4248.md) (Lipomatous Neoplasm) [81][58.26%]
1. [NCIT:C4250](markdown/NCIT_C4250.md) (Well Differentiated Liposarcoma) [2][54.17%]
1. [NCIT:C4318](markdown/NCIT_C4318.md) (Gliomatosis Cerebri) [4][57.14%]
1. [NCIT:C4322](markdown/NCIT_C4322.md) (Fibrillary Astrocytoma) [2][75.00%]
1. [NCIT:C4323](markdown/NCIT_C4323.md) (Pleomorphic Xanthoastrocytoma) [2][62.50%]
1. [NCIT:C4325](markdown/NCIT_C4325.md) (Giant Cell Glioblastoma) [3][66.67%]
1. [NCIT:C4326](markdown/NCIT_C4326.md) (Anaplastic Oligodendroglioma) [5][56.25%]
1. [NCIT:C4337](markdown/NCIT_C4337.md) (Mantle Cell Lymphoma) [14][54.19%]
1. [NCIT:C4340](markdown/NCIT_C4340.md) (Peripheral T-Cell Lymphoma, Not Otherwise Specified) [4][55.00%]
1. [NCIT:C4341](markdown/NCIT_C4341.md) (Marginal Zone Lymphoma) [39][56.06%]
1. [NCIT:C4342](markdown/NCIT_C4342.md) (Intravascular Large B-Cell Lymphoma) [4][66.67%]
1. [NCIT:C4381](markdown/NCIT_C4381.md) (Ovarian Epithelial Tumor) [87][56.35%]
1. [NCIT:C4447](markdown/NCIT_C4447.md) (Benign Retroperitoneal Neoplasm) [10][66.67%]
1. [NCIT:C4456](markdown/NCIT_C4456.md) (Malignant Mesothelioma) [30][55.56%]
1. [NCIT:C4463](markdown/NCIT_C4463.md) (Skin Appendage Neoplasm) [108][56.67%]
1. [NCIT:C4505](markdown/NCIT_C4505.md) (Benign Breast Neoplasm) [18][60.00%]
1. [NCIT:C4508](markdown/NCIT_C4508.md) (Ovarian Seromucinous Tumor) [5][60.91%]
1. [NCIT:C4517](markdown/NCIT_C4517.md) (Benign Fallopian Tube Neoplasm) [6][75.00%]
1. [NCIT:C4536](markdown/NCIT_C4536.md) (Pituitary Gland Carcinoma) [4][91.67%]
1. [NCIT:C4565](markdown/NCIT_C4565.md) (Benign Thoracic Neoplasm) [51][55.28%]
1. [NCIT:C4600](markdown/NCIT_C4600.md) (Benign Salivary Gland Neoplasm) [27][54.55%]
1. [NCIT:C4607](markdown/NCIT_C4607.md) (Benign Myocardial Neoplasm) [2][62.50%]
1. [NCIT:C4610](markdown/NCIT_C4610.md) (Benign Colorectal Neoplasm) [15][60.00%]
1. [NCIT:C4642](markdown/NCIT_C4642.md) (Brain Glioblastoma) [9][55.00%]
1. [NCIT:C4663](markdown/NCIT_C4663.md) (Splenic Marginal Zone Lymphoma) [2][57.14%]
1. [NCIT:C4664](markdown/NCIT_C4664.md) (T-Cell Large Granular Lymphocyte Leukemia) [3][58.33%]
1. [NCIT:C4665](markdown/NCIT_C4665.md) (Plasma Cell Neoplasm) [14][60.00%]
1. [NCIT:C4671](markdown/NCIT_C4671.md) (Breast Lymphoma) [8][75.00%]
1. [NCIT:C4683](markdown/NCIT_C4683.md) (Dermatofibrosarcoma Protuberans) [2][60.00%]
1. [NCIT:C4684](markdown/NCIT_C4684.md) (Nasal Type Extranodal NK/T-Cell Lymphoma) [9][62.05%]
1. [NCIT:C4737](markdown/NCIT_C4737.md) (Enteropathy-Associated T-Cell Lymphoma) [6][60.00%]
1. [NCIT:C4747](markdown/NCIT_C4747.md) (Neuronal and Mixed Neuronal-Glial Tumors) [17][55.48%]
1. [NCIT:C4752](markdown/NCIT_C4752.md) (T-Cell Prolymphocytic Leukemia) [3][54.17%]
1. [NCIT:C4755](markdown/NCIT_C4755.md) (Chondrogenic Neoplasm) [32][56.02%]
1. [NCIT:C4776](markdown/NCIT_C4776.md) (Benign Extrahepatic Bile Duct Neoplasm) [6][52.27%]
1. [NCIT:C4777](markdown/NCIT_C4777.md) (Benign Male Reproductive System Neoplasm) [12][54.17%]
1. [NCIT:C4778](markdown/NCIT_C4778.md) (Benign Kidney Neoplasm) [12][53.80%]
1. [NCIT:C4780](markdown/NCIT_C4780.md) (Benign Eye Neoplasm) [19][54.17%]
1. [NCIT:C4787](markdown/NCIT_C4787.md) (Benign Digestive System Neoplasm) [60][55.18%]
1. [NCIT:C4793](markdown/NCIT_C4793.md) (Colon Lymphoma) [8][62.50%]
1. [NCIT:C4815](markdown/NCIT_C4815.md) (Thyroid Gland Carcinoma) [43][56.19%]
1. [NCIT:C4819](markdown/NCIT_C4819.md) (Skin Squamous Cell Carcinoma) [15][60.00%]
1. [NCIT:C4824](markdown/NCIT_C4824.md) (Tongue Carcinoma) [5][66.67%]
1. [NCIT:C4839](markdown/NCIT_C4839.md) (Esophageal Intraepithelial Neoplasia) [13][57.69%]
1. [NCIT:C4845](markdown/NCIT_C4845.md) (Pancreatic Intraepithelial Neoplasia) [5][54.17%]
1. [NCIT:C4855](markdown/NCIT_C4855.md) (Laryngeal Carcinoma) [34][54.88%]
1. [NCIT:C4861](markdown/NCIT_C4861.md) (Acute Monocytic Leukemia) [3][75.00%]
1. [NCIT:C4862](markdown/NCIT_C4862.md) (Ovarian Sex Cord-Stromal Tumor) [7][55.56%]
1. [NCIT:C4863](markdown/NCIT_C4863.md) (Prostate Carcinoma) [28][55.66%]
1. [NCIT:C4872](markdown/NCIT_C4872.md) (Breast Carcinoma) [115][59.96%]
1. [NCIT:C4878](markdown/NCIT_C4878.md) (Lung Carcinoma) [105][58.07%]
1. [NCIT:C4884](markdown/NCIT_C4884.md) (Benign Neck Neoplasm) [28][56.82%]
1. [NCIT:C4893](markdown/NCIT_C4893.md) (Benign Urinary System Neoplasm) [30][55.08%]
1. [NCIT:C4906](markdown/NCIT_C4906.md) (Parathyroid Gland Carcinoma) [4][66.67%]
1. [NCIT:C4911](markdown/NCIT_C4911.md) (Gastric Carcinoma) [43][54.31%]
1. [NCIT:C4917](markdown/NCIT_C4917.md) (Small Cell Lung Carcinoma) [2][56.76%]
1. [NCIT:C4951](markdown/NCIT_C4951.md) (Cerebral Astrocytoma) [5][75.00%]
1. [NCIT:C4972](markdown/NCIT_C4972.md) (Nerve Sheath Neoplasm) [66][56.59%]
1. [NCIT:C4973](markdown/NCIT_C4973.md) (Perineurioma) [2][58.33%]
1. [NCIT:C5006](markdown/NCIT_C5006.md) (Stage IV Follicular Lymphoma) [3][55.56%]
1. [NCIT:C5007](markdown/NCIT_C5007.md) (Recurrent Follicular Lymphoma) [3][56.26%]
1. [NCIT:C5028](markdown/NCIT_C5028.md) (Verrucous Lesion) [10][57.14%]
1. [NCIT:C5105](markdown/NCIT_C5105.md) (Colorectal Adenocarcinoma) [33][60.00%]
1. [NCIT:C5136](markdown/NCIT_C5136.md) (Childhood Glioblastoma) [6][62.50%]
1. [NCIT:C5160](markdown/NCIT_C5160.md) (Mixed Lobular and Ductal Breast Carcinoma) [6][57.14%]
1. [NCIT:C5197](markdown/NCIT_C5197.md) (Benign Nipple Neoplasm) [2][52.49%]
1. [NCIT:C5206](markdown/NCIT_C5206.md) (Papillary Breast Neoplasm) [13][54.92%]
1. [NCIT:C5226](markdown/NCIT_C5226.md) (Borderline Ovarian Serous Tumor) [2][75.00%]
1. [NCIT:C5237](markdown/NCIT_C5237.md) (Ovarian Neuroendocrine Neoplasm) [5][66.67%]
1. [NCIT:C5242](markdown/NCIT_C5242.md) (Ovarian Mucinous Tumor) [9][66.67%]
1. [NCIT:C5244](markdown/NCIT_C5244.md) (Ovarian Soft Tissue Neoplasm) [13][62.50%]
1. [NCIT:C5265](markdown/NCIT_C5265.md) (Thyroid Gland Lymphoma) [3][75.00%]
1. [NCIT:C5322](markdown/NCIT_C5322.md) (Central Nervous System Anaplastic Large Cell Lymphoma) [2][75.00%]
1. [NCIT:C5340](markdown/NCIT_C5340.md) (Small Intestinal Adenoma) [5][58.33%]
1. [NCIT:C5348](markdown/NCIT_C5348.md) (Great Vessel Neoplasm) [9][80.80%]
1. [NCIT:C5387](markdown/NCIT_C5387.md) (Leiomyosarcoma of Vessels) [5][78.21%]
1. [NCIT:C5495](markdown/NCIT_C5495.md) (Colon Sarcoma) [2][75.00%]
1. [NCIT:C5545](markdown/NCIT_C5545.md) (Prostate Neuroendocrine Neoplasm) [2][75.00%]
1. [NCIT:C5591](markdown/NCIT_C5591.md) (Benign Childhood Central Nervous System Neoplasm) [5][54.17%]
1. [NCIT:C5596](markdown/NCIT_C5596.md) (Prostate Acinar Adenocarcinoma) [2][55.65%]
1. [NCIT:C5669](markdown/NCIT_C5669.md) (Pleuropulmonary Blastoma) [3][60.00%]
1. [NCIT:C5673](markdown/NCIT_C5673.md) (Colorectal Adenoma) [28][55.00%]
1. [NCIT:C5676](markdown/NCIT_C5676.md) (Colorectal Villous Adenoma) [3][66.67%]
1. [NCIT:C5697](markdown/NCIT_C5697.md) (Colon Neuroendocrine Neoplasm) [10][58.33%]
1. [NCIT:C5698](markdown/NCIT_C5698.md) (Rectal Neuroendocrine Neoplasm) [6][75.00%]
1. [NCIT:C5716](markdown/NCIT_C5716.md) (Borderline Exocrine Pancreatic Neoplasm) [13][53.94%]
1. [NCIT:C5749](markdown/NCIT_C5749.md) (Liver and Intrahepatic Bile Duct Benign Non-Epithelial Neoplasm) [6][60.00%]
1. [NCIT:C5803](markdown/NCIT_C5803.md) (Small Intestinal Neuroendocrine Neoplasm) [18][58.33%]
1. [NCIT:C5857](markdown/NCIT_C5857.md) (Extrahepatic Bile Duct Adenoma) [3][75.00%]
1. [NCIT:C5908](markdown/NCIT_C5908.md) (Salivary Gland Mucoepidermoid Carcinoma) [6][66.67%]
1. [NCIT:C6014](markdown/NCIT_C6014.md) (Paranasal Sinus Carcinoma) [12][83.33%]
1. [NCIT:C6120](markdown/NCIT_C6120.md) (Conjunctival Intraepithelial Neoplasia) [2][75.00%]
1. [NCIT:C6287](markdown/NCIT_C6287.md) (Endometrial Endometrioid Adenocarcinoma) [11][56.25%]
1. [NCIT:C6451](markdown/NCIT_C6451.md) (Thymic Lymphoma) [7][55.56%]
1. [NCIT:C6481](markdown/NCIT_C6481.md) (Inflammatory Myofibroblastic Tumor) [9][53.94%]
1. [NCIT:C6514](markdown/NCIT_C6514.md) (Skeletal Muscle Neoplasm) [44][70.83%]
1. [NCIT:C6569](markdown/NCIT_C6569.md) (Congenital Mesoblastic Nephroma) [3][57.14%]
1. [NCIT:C6570](markdown/NCIT_C6570.md) (Extraskeletal Cartilaginous and Osseous Neoplasm) [17][57.14%]
1. [NCIT:C6577](markdown/NCIT_C6577.md) (Myxoma) [11][61.11%]
1. [NCIT:C6591](markdown/NCIT_C6591.md) (Peripheral Neuroblastoma) [2][55.00%]
1. [NCIT:C6603](markdown/NCIT_C6603.md) (Osteogenic Neoplasm) [48][54.88%]
1. [NCIT:C6624](markdown/NCIT_C6624.md) (Mediastinal Neural Neoplasm) [5][75.00%]
1. [NCIT:C6650](markdown/NCIT_C6650.md) (Ampulla of Vater Adenocarcinoma) [5][66.67%]
1. [NCIT:C6657](markdown/NCIT_C6657.md) (Ampulla of Vater Intestinal-Type Adenoma) [3][56.25%]
1. [NCIT:C6770](markdown/NCIT_C6770.md) (Ependymal Tumor) [39][54.77%]
1. [NCIT:C6781](markdown/NCIT_C6781.md) (Stromal Neoplasm) [53][56.51%]
1. [NCIT:C6796](markdown/NCIT_C6796.md) (Eccrine Neoplasm) [13][65.00%]
1. [NCIT:C6798](markdown/NCIT_C6798.md) (Apocrine Neoplasm) [10][80.00%]
1. [NCIT:C6814](markdown/NCIT_C6814.md) (Superficial Fibromatosis) [2][60.00%]
1. [NCIT:C6860](markdown/NCIT_C6860.md) (Primary Cutaneous Anaplastic Large Cell Lymphoma) [2][68.30%]
1. [NCIT:C6881](markdown/NCIT_C6881.md) (Bile Duct Papillary Neoplasm) [7][75.00%]
1. [NCIT:C6930](markdown/NCIT_C6930.md) (Mixed Neoplasm) [185][59.26%]
1. [NCIT:C6958](markdown/NCIT_C6958.md) (Astrocytic Tumor) [116][60.00%]
1. [NCIT:C6959](markdown/NCIT_C6959.md) (Anaplastic Oligoastrocytoma) [3][62.50%]
1. [NCIT:C6960](markdown/NCIT_C6960.md) (Oligodendroglial Tumor) [17][54.19%]
1. [NCIT:C6965](markdown/NCIT_C6965.md) (Pineal Parenchymal Cell Neoplasm) [10][75.00%]
1. [NCIT:C6971](markdown/NCIT_C6971.md) (Meningothelial Cell Neoplasm) [43][60.71%]
1. [NCIT:C6974](markdown/NCIT_C6974.md) (Neoplasm of Uncertain Histogenesis) [5][56.25%]
1. [NCIT:C6990](markdown/NCIT_C6990.md) (Central Nervous System Embryonal Neoplasm) [56][55.66%]
1. [NCIT:C7055](markdown/NCIT_C7055.md) (Precursor Lymphoid Neoplasm) [87][58.20%]
1. [NCIT:C7058](markdown/NCIT_C7058.md) (Melanocytic Neoplasm) [111][56.82%]
1. [NCIT:C7059](markdown/NCIT_C7059.md) (Mesenchymal Cell Neoplasm) [509][67.38%]
1. [NCIT:C7061](markdown/NCIT_C7061.md) (Retinal Cell Neoplasm) [16][54.17%]
1. [NCIT:C7063](markdown/NCIT_C7063.md) (Notochordal Tumor) [6][53.85%]
1. [NCIT:C7064](markdown/NCIT_C7064.md) (Erythroid Neoplasm) [6][54.07%]
1. [NCIT:C7066](markdown/NCIT_C7066.md) (Megakaryocytic Neoplasm) [4][57.50%]
1. [NCIT:C7068](markdown/NCIT_C7068.md) (Neoplastic Polyp) [18][54.07%]
1. [NCIT:C7069](markdown/NCIT_C7069.md) (Giant Cell Neoplasm) [23][54.98%]
1. [NCIT:C7070](markdown/NCIT_C7070.md) (Mucinous Neoplasm) [60][56.67%]
1. [NCIT:C7074](markdown/NCIT_C7074.md) (Serous Neoplasm) [57][55.08%]
1. [NCIT:C7075](markdown/NCIT_C7075.md) (Fibroblastic Neoplasm) [90][58.26%]
1. [NCIT:C7103](markdown/NCIT_C7103.md) (Liver and Intrahepatic Bile Duct Neoplasm) [132][58.32%]
1. [NCIT:C7106](markdown/NCIT_C7106.md) (Liver and Intrahepatic Bile Duct Epithelial Neoplasm) [98][56.74%]
1. [NCIT:C7107](markdown/NCIT_C7107.md) (Liver and Intrahepatic Bile Duct Non-Epithelial Neoplasm) [24][58.33%]
1. [NCIT:C7113](markdown/NCIT_C7113.md) (Endometrioid Tumor) [39][54.19%]
1. [NCIT:C7114](markdown/NCIT_C7114.md) (Thymoma Type B) [5][57.14%]
1. [NCIT:C7128](markdown/NCIT_C7128.md) (Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm) [5][51.76%]
1. [NCIT:C7132](markdown/NCIT_C7132.md) (Glandular Cell Neoplasm) [724][67.67%]
1. [NCIT:C7134](markdown/NCIT_C7134.md) (Bone Surface (Peripheral) Osteosarcoma) [5][62.50%]
1. [NCIT:C7161](markdown/NCIT_C7161.md) (Melanocytic Skin Neoplasm) [66][63.77%]
1. [NCIT:C7164](markdown/NCIT_C7164.md) (Classical Hodgkin Lymphoma) [31][64.98%]
1. [NCIT:C7175](markdown/NCIT_C7175.md) (Acute Myeloid Leukemia with Recurrent Genetic Abnormalities) [29][58.57%]
1. [NCIT:C7195](markdown/NCIT_C7195.md) (Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder) [6][62.90%]
1. [NCIT:C7224](markdown/NCIT_C7224.md) (Plasmablastic Lymphoma) [3][62.50%]
1. [NCIT:C7232](markdown/NCIT_C7232.md) (Neoplastic Post-Transplant Lymphoproliferative Disorder) [16][54.55%]
1. [NCIT:C7233](markdown/NCIT_C7233.md) (Monomorphic Post-Transplant Lymphoproliferative Disorder) [11][53.22%]
1. [NCIT:C7237](markdown/NCIT_C7237.md) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder) [9][52.03%]
1. [NCIT:C7240](markdown/NCIT_C7240.md) (Plasma Cell Post-Transplant Lymphoproliferative Disorder) [2][75.00%]
1. [NCIT:C7258](markdown/NCIT_C7258.md) (Nodular Lymphocyte Predominant Hodgkin Lymphoma) [8][68.30%]
1. [NCIT:C7287](markdown/NCIT_C7287.md) (Ovarian Granulosa-Stromal Cell Tumor) [3][58.33%]
1. [NCIT:C7290](markdown/NCIT_C7290.md) (Ovarian Tumor of the Thecoma/Fibroma Group) [2][66.67%]
1. [NCIT:C7297](markdown/NCIT_C7297.md) (Splenic Manifestation of Prolymphocytic Leukemia) [2][75.00%]
1. [NCIT:C7318](markdown/NCIT_C7318.md) (Acute Monoblastic and Monocytic Leukemia) [9][60.00%]
1. [NCIT:C7335](markdown/NCIT_C7335.md) (Reproductive Endocrine Neoplasm) [15][54.43%]
1. [NCIT:C7355](markdown/NCIT_C7355.md) (Renal Pelvis Urothelial Carcinoma) [5][75.00%]
1. [NCIT:C7372](markdown/NCIT_C7372.md) (Cerebellar Neuronal and Mixed Neuronal-Glial Tumor) [2][55.00%]
1. [NCIT:C7373](markdown/NCIT_C7373.md) (Nasopharyngeal Nonkeratinizing Carcinoma) [7][55.00%]
1. [NCIT:C7376](markdown/NCIT_C7376.md) (Pleural Malignant Mesothelioma) [16][57.98%]
1. [NCIT:C7387](markdown/NCIT_C7387.md) (Blood Vessel Neoplasm) [143][56.74%]
1. [NCIT:C7388](markdown/NCIT_C7388.md) (Vascular Neoplasm) [171][57.19%]
1. [NCIT:C7400](markdown/NCIT_C7400.md) (Burkitt Leukemia) [2][59.09%]
1. [NCIT:C7402](markdown/NCIT_C7402.md) (Hairy Cell Leukemia) [3][64.73%]
1. [NCIT:C7421](markdown/NCIT_C7421.md) (Rectosigmoid Carcinoma) [14][75.00%]
1. [NCIT:C7463](markdown/NCIT_C7463.md) (Acute Myelomonocytic Leukemia) [4][53.94%]
1. [NCIT:C7464](markdown/NCIT_C7464.md) (Acute Leukemia of Ambiguous Lineage) [11][59.09%]
1. [NCIT:C7489](markdown/NCIT_C7489.md) (Anal Canal Carcinoma) [17][62.50%]
1. [NCIT:C7506](markdown/NCIT_C7506.md) (Myelodysplastic Syndrome with Excess Blasts) [3][53.94%]
1. [NCIT:C7528](markdown/NCIT_C7528.md) (Angioimmunoblastic T-Cell Lymphoma) [7][54.17%]
1. [NCIT:C7541](markdown/NCIT_C7541.md) (Retinoblastoma) [13][56.25%]
1. [NCIT:C7558](markdown/NCIT_C7558.md) (Endometrial Carcinoma) [31][54.43%]
1. [NCIT:C7569](markdown/NCIT_C7569.md) (Thymic Carcinoma) [13][53.94%]
1. [NCIT:C7570](markdown/NCIT_C7570.md) (Melanocytic Nevus) [30][53.94%]
1. [NCIT:C7574](markdown/NCIT_C7574.md) (Prostate Phyllodes Tumor) [2][75.00%]
1. [NCIT:C7600](markdown/NCIT_C7600.md) (Acute Myeloid Leukemia with Myelodysplasia-Related Changes) [3][54.66%]
1. [NCIT:C7608](markdown/NCIT_C7608.md) (Benign Oral Neoplasm) [18][54.07%]
1. [NCIT:C7612](markdown/NCIT_C7612.md) (Malignant Thymoma) [8][57.69%]
1. [NCIT:C7617](markdown/NCIT_C7617.md) (Benign Reproductive System Neoplasm) [123][57.19%]
1. [NCIT:C7632](markdown/NCIT_C7632.md) (Pericardial Mesothelioma) [3][75.00%]
1. [NCIT:C7634](markdown/NCIT_C7634.md) (Solitary Fibrous Tumor) [14][59.09%]
1. [NCIT:C7656](markdown/NCIT_C7656.md) (Liver Dysplastic Nodule) [2][66.67%]
1. [NCIT:C7676](markdown/NCIT_C7676.md) (Adenocarcinoma in Adenomatous Polyp) [9][53.01%]
1. [NCIT:C7708](markdown/NCIT_C7708.md) (Childhood Malignant Liver Neoplasm) [11][56.25%]
1. [NCIT:C7718](markdown/NCIT_C7718.md) (Appendix Adenocarcinoma) [6][53.01%]
1. [NCIT:C7720](markdown/NCIT_C7720.md) (Gallbladder Adenoma) [3][75.00%]
1. [NCIT:C7721](markdown/NCIT_C7721.md) (Gingival Carcinoma) [9][80.00%]
1. [NCIT:C7724](markdown/NCIT_C7724.md) (Small Intestinal Carcinoma) [31][54.43%]
1. [NCIT:C7731](markdown/NCIT_C7731.md) (Prostate Sarcoma) [6][75.00%]
1. [NCIT:C7764](markdown/NCIT_C7764.md) (Atypical Lymphoproliferative Disorder) [5][60.00%]
1. [NCIT:C7888](markdown/NCIT_C7888.md) (Small Intestinal Adenocarcinoma) [11][54.17%]
1. [NCIT:C7909](markdown/NCIT_C7909.md) (ACTH-Producing Pituitary Gland Neoplasm) [2][62.50%]
1. [NCIT:C7910](markdown/NCIT_C7910.md) (Prolactin-Producing Pituitary Gland Neoplasm) [2][53.94%]
1. [NCIT:C7911](markdown/NCIT_C7911.md) (Growth Hormone-Producing Pituitary Gland Neoplasm) [2][56.25%]
1. [NCIT:C7915](markdown/NCIT_C7915.md) (TSH-Producing Pituitary Gland Neoplasm) [2][60.00%]
1. [NCIT:C7927](markdown/NCIT_C7927.md) (Liver and Intrahepatic Bile Duct Carcinoma) [79][56.10%]
1. [NCIT:C7933](markdown/NCIT_C7933.md) (Grade III Lymphomatoid Granulomatosis) [5][62.50%]
1. [NCIT:C7975](markdown/NCIT_C7975.md) (Extrahepatic Bile Duct Adenocarcinoma) [7][72.36%]
1. [NCIT:C7992](markdown/NCIT_C7992.md) (Nasopharyngeal Keratinizing Squamous Cell Carcinoma) [7][57.79%]
1. [NCIT:C8054](markdown/NCIT_C8054.md) (Thyroid Gland Follicular Carcinoma) [6][58.33%]
1. [NCIT:C8264](markdown/NCIT_C8264.md) (Childhood Meningioma) [3][58.63%]
1. [NCIT:C8294](markdown/NCIT_C8294.md) (Pancreatic Adenocarcinoma) [18][56.19%]
1. [NCIT:C8300](markdown/NCIT_C8300.md) (Desmoplastic Small Round Cell Tumor) [3][58.33%]
1. [NCIT:C8334](markdown/NCIT_C8334.md) (Squamous Cell Intraepithelial Neoplasia) [33][53.94%]
1. [NCIT:C8383](markdown/NCIT_C8383.md) (Kidney Adenoma) [4][54.55%]
1. [NCIT:C8402](markdown/NCIT_C8402.md) (Fibrohistiocytic Neoplasm) [18][53.94%]
1. [NCIT:C8417](markdown/NCIT_C8417.md) (Benign Ear Neoplasm) [7][53.05%]
1. [NCIT:C8460](markdown/NCIT_C8460.md) (Acute Myeloid Leukemia with Minimal Differentiation) [2][57.14%]
1. [NCIT:C8494](markdown/NCIT_C8494.md) (Lynch Syndrome) [2][68.37%]
1. [NCIT:C8531](markdown/NCIT_C8531.md) (Benign Respiratory Tract Neoplasm) [18][53.05%]
1. [NCIT:C8536](markdown/NCIT_C8536.md) (Benign Pericardial Neoplasm) [2][75.00%]
1. [NCIT:C8563](markdown/NCIT_C8563.md) (Undifferentiated High Grade Pleomorphic Sarcoma of Bone) [6][66.67%]
1. [NCIT:C8591](markdown/NCIT_C8591.md) (Testicular Germ Cell Tumor) [14][54.17%]
1. [NCIT:C8603](markdown/NCIT_C8603.md) (Renal Pelvis Papillary Urothelial Neoplasm) [4][58.33%]
1. [NCIT:C8612](markdown/NCIT_C8612.md) (Benign Peritoneal Neoplasm) [2][75.00%]
1. [NCIT:C8694](markdown/NCIT_C8694.md) (T Lymphoblastic Leukemia/Lymphoma) [18][54.43%]
1. [NCIT:C8851](markdown/NCIT_C8851.md) (Diffuse Large B-Cell Lymphoma) [88][57.74%]
1. [NCIT:C8859](markdown/NCIT_C8859.md) (Stage I Follicular Lymphoma) [3][55.56%]
1. [NCIT:C8860](markdown/NCIT_C8860.md) (Stage II Follicular Lymphoma) [3][55.56%]
1. [NCIT:C8861](markdown/NCIT_C8861.md) (Stage III Follicular Lymphoma) [3][55.56%]
1. [NCIT:C8863](markdown/NCIT_C8863.md) (Nodal Marginal Zone Lymphoma) [7][58.33%]
1. [NCIT:C8936](markdown/NCIT_C8936.md) (B Lymphoblastic Leukemia/Lymphoma) [33][56.35%]
1. [NCIT:C8964](markdown/NCIT_C8964.md) (Synovial Neoplasm) [5][53.22%]
1. [NCIT:C8968](markdown/NCIT_C8968.md) (Grade 2 Follicular Lymphoma) [6][54.17%]
1. [NCIT:C8971](markdown/NCIT_C8971.md) (Embryonal Rhabdomyosarcoma) [3][60.00%]
1. [NCIT:C8978](markdown/NCIT_C8978.md) (Mucinous Adenofibroma) [3][75.00%]
1. [NCIT:C8984](markdown/NCIT_C8984.md) (Female Reproductive System Adenofibroma) [29][57.14%]
1. [NCIT:C8990](markdown/NCIT_C8990.md) (Oral Cavity Carcinoma) [53][64.29%]
1. [NCIT:C9003](markdown/NCIT_C9003.md) (Adrenal Cortex Adenoma) [3][60.00%]
1. [NCIT:C9039](markdown/NCIT_C9039.md) (Cervical Carcinoma) [40][54.66%]
1. [NCIT:C9055](markdown/NCIT_C9055.md) (Bartholin Gland Carcinoma) [6][66.67%]
1. [NCIT:C9087](markdown/NCIT_C9087.md) (Kaposi Sarcoma) [30][56.25%]
1. [NCIT:C9093](markdown/NCIT_C9093.md) (Adult Meningioma) [6][58.63%]
1. [NCIT:C9094](markdown/NCIT_C9094.md) (Adult Glioblastoma) [5][56.25%]
1. [NCIT:C9105](markdown/NCIT_C9105.md) (Oropharyngeal Carcinoma) [27][66.67%]
1. [NCIT:C9118](markdown/NCIT_C9118.md) (Sarcoma) [451][65.45%]
1. [NCIT:C9120](markdown/NCIT_C9120.md) (Pancreatic Ductal Adenocarcinoma) [9][55.93%]
1. [NCIT:C9133](markdown/NCIT_C9133.md) (Adenosquamous Lung Carcinoma) [7][58.33%]
1. [NCIT:C9152](markdown/NCIT_C9152.md) (Superficial Spreading Melanoma) [4][66.67%]
1. [NCIT:C9161](markdown/NCIT_C9161.md) (Anal Squamous Cell Carcinoma) [5][75.00%]
1. [NCIT:C9166](markdown/NCIT_C9166.md) (Gallbladder Adenocarcinoma) [8][55.56%]
1. [NCIT:C9182](markdown/NCIT_C9182.md) (Desmoid-Type Fibromatosis) [4][57.14%]
1. [NCIT:C9231](markdown/NCIT_C9231.md) (Merkel Cell Carcinoma) [9][66.67%]
1. [NCIT:C9235](markdown/NCIT_C9235.md) (Systemic Mastocytosis) [7][66.67%]
1. [NCIT:C9240](markdown/NCIT_C9240.md) (Recurrent Nasopharynx Carcinoma) [2][57.79%]
1. [NCIT:C9265](markdown/NCIT_C9265.md) (Mycosis Fungoides and Sezary Syndrome) [15][61.11%]
1. [NCIT:C9280](markdown/NCIT_C9280.md) (Mediastinal (Thymic) Large B-Cell Lymphoma) [6][58.33%]
1. [NCIT:C9287](markdown/NCIT_C9287.md) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11) [4][54.17%]
1. [NCIT:C9290](markdown/NCIT_C9290.md) (Myeloid Neoplasm) [178][65.49%]
1. [NCIT:C9292](markdown/NCIT_C9292.md) (Solid Neoplasm) [6][53.87%]
1. [NCIT:C9294](markdown/NCIT_C9294.md) (Histiocytic and Dendritic Cell Neoplasm) [26][54.66%]
1. [NCIT:C9295](markdown/NCIT_C9295.md) (Mast Cell Neoplasm) [14][66.67%]
1. [NCIT:C9308](markdown/NCIT_C9308.md) (Lymphoproliferative Disorder) [774][69.29%]
1. [NCIT:C9309](markdown/NCIT_C9309.md) (Seminoma) [4][60.00%]
1. [NCIT:C9312](markdown/NCIT_C9312.md) (Bone Sarcoma) [51][56.43%]
1. [NCIT:C9325](markdown/NCIT_C9325.md) (Adrenal Cortex Carcinoma) [7][58.33%]
1. [NCIT:C9336](markdown/NCIT_C9336.md) (Nasal Cavity Carcinoma) [10][75.00%]
1. [NCIT:C9347](markdown/NCIT_C9347.md) (Tracheal Carcinoma) [3][75.00%]
1. [NCIT:C9349](markdown/NCIT_C9349.md) (Plasmacytoma) [4][66.67%]
1. [NCIT:C9351](markdown/NCIT_C9351.md) (Pleural Mesothelioma) [19][53.94%]
1. [NCIT:C9357](markdown/NCIT_C9357.md) (Hodgkin Lymphoma) [75][66.67%]
1. [NCIT:C9360](markdown/NCIT_C9360.md) (Lymphoblastic Lymphoma) [28][55.56%]
1. [NCIT:C9385](markdown/NCIT_C9385.md) (Renal Cell Carcinoma) [28][57.04%]
1. [NCIT:C9474](markdown/NCIT_C9474.md) (Adenosarcoma) [5][58.33%]
1. [NCIT:C9475](markdown/NCIT_C9475.md) (Cerebellar Astrocytoma) [4][75.00%]
1. [NCIT:C9477](markdown/NCIT_C9477.md) (Anaplastic Astrocytoma) [14][54.55%]
1. [NCIT:C9482](markdown/NCIT_C9482.md) (Soft Tissue Chondroma) [3][75.00%]
1. [NCIT:C26323](markdown/NCIT_C26323.md) (Hematologic and Lymphocytic Disorder) [1040][74.95%]
1. [NCIT:C26712](markdown/NCIT_C26712.md) (Mucinous Adenocarcinoma) [41][64.29%]
1. [NCIT:C27042](markdown/NCIT_C27042.md) (Soft Tissue Disorder) [566][66.24%]
1. [NCIT:C27067](markdown/NCIT_C27067.md) (Endocrine Pancreas Disorder) [34][55.28%]
1. [NCIT:C27134](markdown/NCIT_C27134.md) (Hematopoietic and Lymphoid Cell Neoplasm) [1009][74.84%]
1. [NCIT:C27262](markdown/NCIT_C27262.md) (Myelodysplastic/Myeloproliferative Neoplasm) [10][55.66%]
1. [NCIT:C27269](markdown/NCIT_C27269.md) (Glandular Cell Intraepithelial Neoplasia) [46][56.59%]
1. [NCIT:C27291](markdown/NCIT_C27291.md) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) [30][54.31%]
1. [NCIT:C27380](markdown/NCIT_C27380.md) (Thyroid Gland Adenocarcinoma) [24][54.98%]
1. [NCIT:C27423](markdown/NCIT_C27423.md) (Esophageal Squamous Intraepithelial Neoplasia) [3][64.29%]
1. [NCIT:C27462](markdown/NCIT_C27462.md) (Small Intestinal Intraepithelial Neoplasia) [2][66.67%]
1. [NCIT:C27467](markdown/NCIT_C27467.md) (Stage 0 Lung Cancer AJCC v6 and v7) [4][75.00%]
1. [NCIT:C27531](markdown/NCIT_C27531.md) (Pre-Malignant Skin Epithelial Lesion) [4][58.33%]
1. [NCIT:C27669](markdown/NCIT_C27669.md) (Respiratory and Thoracic Disorder) [387][62.62%]
1. [NCIT:C27695](markdown/NCIT_C27695.md) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder) [2][62.50%]
1. [NCIT:C27696](markdown/NCIT_C27696.md) (EBV-Related Post-Transplant Lymphoproliferative Disorder) [3][58.33%]
1. [NCIT:C27716](markdown/NCIT_C27716.md) (Extragastrointestinal Gastrointestinal Stromal Tumor) [3][60.00%]
1. [NCIT:C27720](markdown/NCIT_C27720.md) (Pancreatic Neuroendocrine Tumor) [25][54.66%]
1. [NCIT:C27721](markdown/NCIT_C27721.md) (Digestive System Neuroendocrine Neoplasm) [181][57.12%]
1. [NCIT:C27814](markdown/NCIT_C27814.md) (Bile Duct Carcinoma) [68][63.71%]
1. [NCIT:C27881](markdown/NCIT_C27881.md) (Transitional Cell Intraepithelial Neoplasia) [17][53.85%]
1. [NCIT:C27885](markdown/NCIT_C27885.md) (Infiltrating Bladder Urothelial Carcinoma) [14][55.18%]
1. [NCIT:C27897](markdown/NCIT_C27897.md) (T-Cell Proliferation of Uncertain Malignant Potential) [7][54.55%]
1. [NCIT:C27907](markdown/NCIT_C27907.md) (B-Cell Neoplasm) [351][64.34%]
1. [NCIT:C27908](markdown/NCIT_C27908.md) (T-Cell and NK-Cell Neoplasm) [151][60.52%]
1. [NCIT:C27909](markdown/NCIT_C27909.md) (Mature T-Cell and NK-Cell Neoplasm) [120][59.54%]
1. [NCIT:C27910](markdown/NCIT_C27910.md) (Mature B-Cell Neoplasm) [308][62.90%]
1. [NCIT:C27911](markdown/NCIT_C27911.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) [28][55.18%]
1. [NCIT:C27913](markdown/NCIT_C27913.md) (Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome) [2][56.25%]
1. [NCIT:C27939](markdown/NCIT_C27939.md) (Lobular Neoplasia) [2][54.17%]
1. [NCIT:C27942](markdown/NCIT_C27942.md) (Intraductal Proliferative Lesion of the Breast) [4][71.43%]
1. [NCIT:C34803](markdown/NCIT_C34803.md) (Primary Malignant Liver Neoplasm) [100][57.47%]
1. [NCIT:C35417](markdown/NCIT_C35417.md) (Intrahepatic Cholangiocarcinoma) [18][68.75%]
1. [NCIT:C35562](markdown/NCIT_C35562.md) (Neuroepithelial, Perineurial, and Schwann Cell Neoplasm) [375][63.83%]
1. [NCIT:C35870](markdown/NCIT_C35870.md) (Conventional Osteosarcoma) [4][54.17%]
1. [NCIT:C36055](markdown/NCIT_C36055.md) (Acute Myeloid Leukemia with a Variant RARA Translocation) [4][54.19%]
1. [NCIT:C36083](markdown/NCIT_C36083.md) (Intraductal Breast Neoplasm) [13][58.30%]
1. [NCIT:C36207](markdown/NCIT_C36207.md) (Digestive System Adenoma) [58][55.84%]
1. [NCIT:C36312](markdown/NCIT_C36312.md) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1) [2][56.25%]
1. [NCIT:C37193](markdown/NCIT_C37193.md) (Anaplastic Large Cell Lymphoma, ALK-Positive) [2][54.31%]
1. [NCIT:C37194](markdown/NCIT_C37194.md) (Anaplastic Large Cell Lymphoma, ALK-Negative) [2][75.00%]
1. [NCIT:C37201](markdown/NCIT_C37201.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation) [2][66.67%]
1. [NCIT:C37204](markdown/NCIT_C37204.md) (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene) [2][58.33%]
1. [NCIT:C37263](markdown/NCIT_C37263.md) (Mixed Epithelial Stromal Tumor of the Kidney) [2][62.50%]
1. [NCIT:C37266](markdown/NCIT_C37266.md) (Bladder Flat Intraepithelial Lesion) [2][54.55%]
1. [NCIT:C38342](markdown/NCIT_C38342.md) (Pancreatic Intraductal Papillary-Mucinous Neoplasm) [5][56.25%]
1. [NCIT:C38458](markdown/NCIT_C38458.md) (Traditional Serrated Adenoma) [4][55.00%]
1. [NCIT:C38936](markdown/NCIT_C38936.md) (Grade I Meningioma) [12][53.94%]
1. [NCIT:C38937](markdown/NCIT_C38937.md) (Grade II Meningioma) [6][53.94%]
1. [NCIT:C38938](markdown/NCIT_C38938.md) (Grade III Meningioma) [7][53.85%]
1. [NCIT:C39749](markdown/NCIT_C39749.md) (Type II Endometrial Adenocarcinoma) [4][52.03%]
1. [NCIT:C39750](markdown/NCIT_C39750.md) (Glioblastoma, IDH-Wildtype) [11][56.25%]
1. [NCIT:C39851](markdown/NCIT_C39851.md) (Bladder Urothelial Carcinoma) [23][55.66%]
1. [NCIT:C39852](markdown/NCIT_C39852.md) (Urothelial Neoplasm) [71][56.74%]
1. [NCIT:C39857](markdown/NCIT_C39857.md) (Bladder Papillary Urothelial Neoplasm) [6][53.85%]
1. [NCIT:C39879](markdown/NCIT_C39879.md) (Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma) [3][62.50%]
1. [NCIT:C39904](markdown/NCIT_C39904.md) (Tumor of Specialized Prostatic Stroma) [2][75.00%]
1. [NCIT:C39950](markdown/NCIT_C39950.md) (Tumor of the Thecoma/Fibroma Group) [3][68.30%]
1. [NCIT:C40022](markdown/NCIT_C40022.md) (Primary Peritoneal Carcinoma) [7][55.00%]
1. [NCIT:C40035](markdown/NCIT_C40035.md) (Adenocarcinofibroma) [3][75.00%]
1. [NCIT:C40076](markdown/NCIT_C40076.md) (Ovarian Clear Cell Tumor) [11][52.49%]
1. [NCIT:C40077](markdown/NCIT_C40077.md) (Malignant Ovarian Clear Cell Tumor) [3][52.03%]
1. [NCIT:C40101](markdown/NCIT_C40101.md) (Serous Adenocarcinoma) [25][53.80%]
1. [NCIT:C40102](markdown/NCIT_C40102.md) (Fallopian Tube Serous Neoplasm) [7][54.17%]
1. [NCIT:C40106](markdown/NCIT_C40106.md) (Borderline Fallopian Tube Neoplasm) [3][66.67%]
1. [NCIT:C40109](markdown/NCIT_C40109.md) (Fallopian Tube Mucinous Neoplasm) [2][75.00%]
1. [NCIT:C40135](markdown/NCIT_C40135.md) (Uterine Ligament Adenocarcinoma) [7][75.00%]
1. [NCIT:C40179](markdown/NCIT_C40179.md) (Uterine Corpus Soft Tissue Neoplasm) [31][54.76%]
1. [NCIT:C40181](markdown/NCIT_C40181.md) (Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm) [7][55.00%]
1. [NCIT:C40195](markdown/NCIT_C40195.md) (Cervical Squamous Neoplasm) [18][55.56%]
1. [NCIT:C40210](markdown/NCIT_C40210.md) (Cervical Glandular Neoplasm) [20][55.00%]
1. [NCIT:C40216](markdown/NCIT_C40216.md) (Cervical Soft Tissue Neoplasm) [11][62.50%]
1. [NCIT:C40226](markdown/NCIT_C40226.md) (Cervical Mixed Epithelial and Mesenchymal Neoplasm) [6][55.00%]
1. [NCIT:C40242](markdown/NCIT_C40242.md) (Vaginal Squamous Neoplasm) [8][62.50%]
1. [NCIT:C40250](markdown/NCIT_C40250.md) (Vaginal Glandular Neoplasm) [10][66.67%]
1. [NCIT:C40265](markdown/NCIT_C40265.md) (Vaginal Soft Tissue Neoplasm) [7][75.00%]
1. [NCIT:C40283](markdown/NCIT_C40283.md) (Vulvar Squamous Neoplasm) [11][58.33%]
1. [NCIT:C40292](markdown/NCIT_C40292.md) (Vulvar Glandular Neoplasm) [13][66.67%]
1. [NCIT:C40303](markdown/NCIT_C40303.md) (Vulvar Neoplasm of Skin Appendage Origin) [12][75.00%]
1. [NCIT:C40316](markdown/NCIT_C40316.md) (Vulvar Soft Tissue Neoplasm) [9][75.00%]
1. [NCIT:C40389](markdown/NCIT_C40389.md) (Breast Myoepithelial Tumor) [6][62.50%]
1. [NCIT:C40392](markdown/NCIT_C40392.md) (Myoepithelial Tumor) [15][61.11%]
1. [NCIT:C40405](markdown/NCIT_C40405.md) (Breast Fibroepithelial Neoplasm) [10][66.67%]
1. [NCIT:C40407](markdown/NCIT_C40407.md) (Kidney Wilms Tumor) [16][66.67%]
1. [NCIT:C40409](markdown/NCIT_C40409.md) (Salivary Gland Pleomorphic Adenoma) [2][60.00%]
1. [NCIT:C40970](markdown/NCIT_C40970.md) (Angiocentric Immunoproliferative Lesion) [15][55.56%]
1. [NCIT:C41247](markdown/NCIT_C41247.md) (Pancreatic Mucinous-Cystic Neoplasm) [4][58.33%]
1. [NCIT:C41248](markdown/NCIT_C41248.md) (Pancreatic Serous Neoplasm) [6][57.14%]
1. [NCIT:C43313](markdown/NCIT_C43313.md) (Pilar-Associated Mesenchyme Neoplasm) [5][66.67%]
1. [NCIT:C43324](markdown/NCIT_C43324.md) (Outer Hair Sheath and Infundibulum Neoplasm) [10][61.11%]
1. [NCIT:C43527](markdown/NCIT_C43527.md) (Sporadic Gastric Adenocarcinoma) [13][56.25%]
1. [NCIT:C43550](markdown/NCIT_C43550.md) (Appendix Adenoma) [5][62.50%]
1. [NCIT:C43587](markdown/NCIT_C43587.md) (Colorectal Small Cell Neuroendocrine Carcinoma) [2][76.73%]
1. [NCIT:C43590](markdown/NCIT_C43590.md) (Colorectal Medullary Carcinoma) [2][75.00%]
1. [NCIT:C45194](markdown/NCIT_C45194.md) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type) [2][60.00%]
1. [NCIT:C45332](markdown/NCIT_C45332.md) (Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype) [2][55.56%]
1. [NCIT:C45612](markdown/NCIT_C45612.md) (Lung Soft Tissue Neoplasm) [11][66.67%]
1. [NCIT:C45625](markdown/NCIT_C45625.md) (Malignant Lung and Pleural Neoplasm) [4][57.14%]
1. [NCIT:C45837](markdown/NCIT_C45837.md) (Non-Functional Pancreatic Neuroendocrine Tumor) [3][63.18%]
1. [NCIT:C45843](markdown/NCIT_C45843.md) (Pancreatic Carcinoma with Mixed Differentiation) [3][60.00%]
1. [NCIT:C45915](markdown/NCIT_C45915.md) (Gonadotropin-Producing Pituitary Gland Adenoma) [2][80.00%]
1. [NCIT:C48306](markdown/NCIT_C48306.md) (Adrenal Gland Composite Pheochromocytoma) [2][66.67%]
1. [NCIT:C48596](markdown/NCIT_C48596.md) (Invasive Prostate Carcinoma) [19][54.77%]
1. [NCIT:C49166](markdown/NCIT_C49166.md) (Extracardiac Rhabdomyoma) [6][71.62%]
1. [NCIT:C53459](markdown/NCIT_C53459.md) (Chondroma) [6][57.14%]
1. [NCIT:C53972](markdown/NCIT_C53972.md) (Erdheim-Chester Disease) [2][66.67%]
1. [NCIT:C61574](markdown/NCIT_C61574.md) (Uterine Corpus Cancer) [34][54.88%]
1. [NCIT:C65151](markdown/NCIT_C65151.md) (Non-Small Cell Carcinoma) [63][56.43%]
1. [NCIT:C66950](markdown/NCIT_C66950.md) (Hepatoid Adenocarcinoma) [4][75.00%]
1. [NCIT:C67155](markdown/NCIT_C67155.md) (Olfactory Neurogenic Tumor) [5][55.56%]
1. [NCIT:C68627](markdown/NCIT_C68627.md) (Childhood Extracranial Germ Cell Tumor) [4][60.00%]
1. [NCIT:C79951](markdown/NCIT_C79951.md) (Papillary Adenoma) [7][53.85%]
1. [NCIT:C80280](markdown/NCIT_C80280.md) (Diffuse Large B-Cell Lymphoma, Not Otherwise Specified) [24][56.54%]
1. [NCIT:C80291](markdown/NCIT_C80291.md) (High Grade B-Cell Lymphoma, Not Otherwise Specified) [2][66.98%]
1. [NCIT:C80308](markdown/NCIT_C80308.md) (Splenic B-Cell Lymphoma/Leukemia, Unclassifiable) [2][66.67%]
1. [NCIT:C80331](markdown/NCIT_C80331.md) (B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1) [3][55.56%]
1. [NCIT:C80683](markdown/NCIT_C80683.md) (Therapy-Related Leukemia) [4][55.56%]
1. [NCIT:C82338](markdown/NCIT_C82338.md) (Myeloid Proliferations Related to Down Syndrome) [2][55.56%]
1. [NCIT:C84270](markdown/NCIT_C84270.md) (Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2) [5][54.07%]
1. [NCIT:C88981](markdown/NCIT_C88981.md) (Stage I Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C88982](markdown/NCIT_C88982.md) (Stage II Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C88983](markdown/NCIT_C88983.md) (Stage III Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C88984](markdown/NCIT_C88984.md) (Stage IV Nasopharyngeal Carcinoma AJCC v7) [2][57.79%]
1. [NCIT:C94540](markdown/NCIT_C94540.md) (Anterior Pituitary Gland Endocrine Neoplasm) [35][57.61%]
1. [NCIT:C95406](markdown/NCIT_C95406.md) (Digestive System Mixed Adenoneuroendocrine Carcinoma) [15][56.25%]
1. [NCIT:C95909](markdown/NCIT_C95909.md) (Preinvasive Neoplasm of the Ampullary Region) [8][55.00%]
1. [NCIT:C96414](markdown/NCIT_C96414.md) (Sessile Serrated Adenoma/Polyp) [4][56.25%]
1. [NCIT:C96756](markdown/NCIT_C96756.md) (Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm) [5][56.25%]
1. [NCIT:C114801](markdown/NCIT_C114801.md) (Childhood Gonadal Germ Cell Tumor) [3][53.87%]
1. [NCIT:C114940](markdown/NCIT_C114940.md) (Malignant Cardiovascular Neoplasm) [110][56.02%]
1. [NCIT:C121671](markdown/NCIT_C121671.md) (Angiosarcoma of Soft Tissue) [18][60.00%]
1. [NCIT:C121974](markdown/NCIT_C121974.md) (Ph-Like Acute Lymphoblastic Leukemia) [2][66.67%]
1. [NCIT:C123329](markdown/NCIT_C123329.md) (Multiple Endocrine Neoplasia Type 2) [2][75.00%]
1. [NCIT:C131610](markdown/NCIT_C131610.md) (Ependymal Tumor of Brain and Spinal Cord) [2][64.05%]
1. [NCIT:C134604](markdown/NCIT_C134604.md) (Intrahepatic Bile Duct Cancer by AJCC v8 Stage) [11][75.00%]
1. [NCIT:C136610](markdown/NCIT_C136610.md) (Bone Cancer by AJCC v7 Stage) [14][66.67%]
1. [NCIT:C136612](markdown/NCIT_C136612.md) (Bone Cancer by AJCC v8 Stage) [4][66.67%]
1. [NCIT:C136694](markdown/NCIT_C136694.md) (Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage) [4][75.00%]
1. [NCIT:C136769](markdown/NCIT_C136769.md) (Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage) [4][60.00%]
1. [NCIT:C138195](markdown/NCIT_C138195.md) (High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements) [2][62.50%]

